Skip to content


Recent advances in systemic therapy

Paul Ellis

  1. Content type: Review

    Human epidermal growth factor receptor (HER)2 over-expression is associated with a shortened disease-free interval and poor survival. Although the addition of trastuzumab to chemotherapy in the first-line sett...

    Authors: Phuong Khanh H Morrow, Francisco Zambrana and Francisco J Esteva

    Citation: Breast Cancer Research 2009 11:207

    Published on:

  2. Content type: Review

    The key to optimising our approach in early breast cancer is to individualise care. Each patient has a tumour with innate features that dictate their chance of relapse and their responsiveness to treatment. Of...

    Authors: Catherine Oakman, Silvia Bessi, Elena Zafarana, Francesca Galardi, Laura Biganzoli and Angelo Di Leo

    Citation: Breast Cancer Research 2009 11:205

    Published on: